Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015 (2015), Article ID 102582, 8 pages
http://dx.doi.org/10.1155/2015/102582
Clinical Study

Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity

1Department of Ophthalmology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania
2“Alfred Rusescu” Institute for Mother and Child Care, 120 Lacul Tei Boulevard, 020395 Bucharest, Romania
3Department of Neuroscience, “Iuliu Hațieganu” University of Medicine and Pharmacy, 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania
4Department of Ophthalmology, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania
5Department of Neonatology, “Iuliu Hațieganu” University of Medicine and Pharmacy, 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania
6Department of Medical Informatics and Biostatistics, “Iuliu Hațieganu” University of Medicine and Pharmacy, 8 Victor Babeș Street, 400012 Cluj-Napoca, Romania

Received 8 December 2014; Revised 7 March 2015; Accepted 23 March 2015

Academic Editor: Juliana L. Dreyfuss

Copyright © 2015 Simona Delia Nicoară et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Simona Delia Nicoară, Constanța Nascutzy, Cristina Cristian, et al., “Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity,” Journal of Ophthalmology, vol. 2015, Article ID 102582, 8 pages, 2015. doi:10.1155/2015/102582